Creative Diagnostics has launched SARS-CoV-2 immunoassay kits for direct detection of SARS-CoV-2 antigens and antibodies. 

New immunoassay kits including SARS-CoV-2 IgG ELISA Kit, SARS-CoV-2 IgM ELISA Kit, SARS-CoV-2 Antigen ELISA Kit, and SARS-COV-2 Total Antibody ELISA Kit are now available from Creative Diagnostics.

In the early days of this pandemic, Creative Diagnostics launched two ELISAs for the detection of Anti-SARS-CoV-2 antibodies of classes IgM and IgG and one ELISA for the detection of SARS-CoV-2 NP antigen. 

Both test systems are currently only available to research institutions as research-use-only products. Preparations for CE registration of these tests are underway.

The SARS-CoV-2 Antigen ELISA Kit is based on the principle of a double-antibody sandwich enzyme-linked immunoassay.

This kit is intended for the quantitative detection of the recombinant SARS-COV-2 nucleoprotein antigen in human serum.

Creative Diagnostics state "the kit recognizes recombinant SARS-CoV Nucleoprotein / NP Protein, but doesn't react with recombinant MERS-CoV Nucleoprotein / NP protein", and, "for use on natural samples, it will need to be validated by the end-user, due to the complexity of natural targets and unpredictable interference." 

It is worth noting that it is for research use only, not for use in diagnostic procedures.

"To provide an opportunity to address existing issues, we'll strengthen our capabilities in developing quality diagnostic kits especially immunoassay kits for the research community, and we'll also focus on the custom solutions that support research needs to fight against the SARS-CoV-2." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

If you want to know more information about SARS-CoV-2 immunoassay kits or other coronavirus research materials, please contact Creative Diagnostics at +1-631-619-7922 or use the 'Request Information' button provided below.